Uniting our global researchers for melanoma
28 October 2016
Melanoma Institute Australia (MIA) is bringing to Sydney some of the world’s leading melanoma researchers and clinicians today for the Australasian Melanoma Conference.
More than 380 researchers, clinicians, nurses and students are attending the two-day conference held at the Sofitel Wentworth in Sydney. The conference, hosted by MIA, is bringing together some of the greatest minds in melanoma research to showcase current practice and research innovation that will make a difference to the lives of melanoma patients.
MIA’s Associate Professor Robyn Saw, Chair of the Australasian Melanoma Conference, says this year’s event is an opportunity for physicians and researchers to learn about ground-breaking research and revolutionary melanoma treatment.
“The conference is a truly unique opportunity to build strong Australasian collaboration and to acquire information and knowledge to use in every day practice,” Associate Professor Saw says.
During the conference, MIA’s Associate Professor Jonathan Stretch AM is launching the new eBook Melanoma Principles & Practice, an interactive multi-touch e-textbook on melanoma care and treatment aimed at specialists.
Written and designed by MIA, the eBook is set to become an ultimate resource on melanoma, delivering specialists a seamless experience that supplements the text with interactive visual supports to build a multi-dimensional level of understanding that would not be possible from a printed book.
The Conference features a number of international keynote speakers. Dr Vernon Sondak from the Moffitt Cancer Center in the US is discussing melanoma in children and how to improve diagnosis and management, as well as communication with the young patient and their family.
Associate Professor Jennifer Wargo from MD Anderson Cancer Center is discussing her research on how gut flora – known as the microbiome – play a role in determining how well a patient responds to treatment.
“There is emerging evidence regarding the role of the microbiome in response to melanoma therapy, and it is quite likely that we will modify the microbiome to enhance responses to therapy in the upcoming months and years,” says Associate Professor Wargo.
Professor John Thompson AO from MIA is reporting on the new electronic clinical practice guidelines for the diagnosis and management of melanoma.
“Things are moving quickly in melanoma management. A comprehensive systematic review of the evidence was timely," Professor Thompson says. “Extensive use of the new guidelines will help to ensure that clinicians have access to the latest evidence-based recommendations when diagnosing and caring for people with melanoma."
More than 30 speakers are presenting at the Australasian Melanoma Conference, including a contingent of MIA experts such as Professor Richard Scolyer and Professor Georgina Long, as well as other eminent Australians in the field such as Professor Grant McArthur and Dr Mark Shackleton from the Peter MacCallum Cancer Centre.
Delegates are sharing insights and key learnings on social media throughout the day using the hashtag #MelanomaConf2016.
The Australasian Melanoma Conference is proudly sponsored by Bristol-Myers Squibb, MSD, Novartis, Sonic Healthcare, Amgen, Laverty Pathology and Pierre Fabre Australia.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.
Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.
Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.
‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.’
The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.
Professor Georgina Long and Professor Richard Scolyer have been recognised as world leaders in melanoma research for their ground-breaking work that has changed the diagnosis and treatment landscape of melanoma world-wide, and tripled the life-expectancy of advanced melanoma patients.
Leading researchers from Melanoma Institute Australia have taken out the top accolades at the NSW Premier’s Awards for Outstanding Cancer Research.